RohamTZamanianMD
Pulmonology • Stanford, CACritical Care Medicine, Pleural Disease
Assistant Professor, Medicine - Pulmonary & Critical Care Medicine, Stanford University Medical Center
Dr. Zamanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
University of California (Irvine)Residency, Internal Medicine, 1999 - 2002
University of California, Irvine, School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Insulin Resistance in Pulmonary Arterial Hypertension Start of enrollment: 2008 Sep 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil). Start of enrollment: 2010 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsNOVEL MECHANISMS TARGETED BY DRUG TRIALS IN PULMONARY ARTERIAL HYPERTENSIONDavid Condon, Stuti Agarwal, Ananya Chakraborty, Natasha Auer, Rocio Vazquez
Chest. 2021-10-13 - 50 citationsSafety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind,...Roham T. Zamanian, David B. Badesch, Lorinda Chung, Robyn T. Domsic, Thomas A. Medsger
American Journal of Respiratory and Critical Care Medicine. 2021-03-02 - 314 citationsCharacterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL: Identifying Systemic Sclerosis as a Unique PhenotypeLorinda Chung, Juliana Liu, Lori Parsons, Paul M. Hassoun, Michael D. McGoon
Chest. 2010-12-01
Authored Content
- Pulmonary Vascular Fellowship Training to Promote Excellence in PH Clinical Care: The Stanford PerspectiveSeptember 2020
Press Mentions
Hemodynamic Trajectories and Outcomes in Patients with Pulmonary Arterial HypertensionDecember 6th, 2020
Inhaled Nitric Oxide Explored for COVID-19 OxygenationMay 13th, 2020
Inhaled Nitric Oxide Scan for COVID-19 OxygenationMay 13th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
